Skip to main content
AIBD Regionals Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Friday, March 31, 2023
  • 1:15 PM – 2:00 PM .
    Welcome and Session I: 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 2:00 PM – 3:00 PM .
    Non-CME Innovation Theater
  • 3:00 PM – 3:45 PM .
    Session II: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 3:45 PM – 4:45 PM .
    Non-CME Innovation Theater
  • 5:00 PM – 5:45 PM .
    Session III: Stricturing Crohn's Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Saturday, April 1, 2023
  • 6:45 AM – 7:45 AM .
    Non-CME Innovation Theater
  • 8:00 AM – 8:15 AM .
    Session IV
  • 8:15 AM – 9:00 AM .
    Session IV: Special Situations in UC
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
  • 9:00 AM – 9:45 AM .
    Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
  • 9:45 AM – 10:30 AM .
    Session VI: Special Situations in IBD
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
  • 11:00 AM – 12:00 PM .
    Lunch and Exhibit Hall Break
  • 12:15 PM – 1:00 PM .
    Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:00 PM – 1:45 PM .
    Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine
  • 2:00 PM – 3:00 PM .
    Non-CME Innovation Theater
  • 3:15 PM – 4:00 PM .
    Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:00 PM – 4:45 PM .
    Session X: Putting your knowledge to the test: Challenging IBD cases
  • Thursday, April 20, 2023
  • 12:00 PM – 12:15 PM .
    Welcome
  • 12:15 PM – 1:00 PM .
    Session I: 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater
  • 2:30 PM – 3:15 PM .
    Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 3:30 PM – 4:30 PM .
    Non-CME Innovation Theater
  • 4:45 PM – 5:30 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Friday, April 21, 2023
  • 8:00 AM – 8:15 AM .
    Welcome
  • 8:15 AM – 9:00 AM .
    Session IV: Special Situations in UC
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
  • 9:15 AM – 10:00 AM .
    Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 10:15 AM – 11:15 AM .
    Non-CME Innovation Theater
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 12:30 PM – 1:15 PM .
    Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater
  • 2:45 PM – 3:30 PM .
    Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG – University of Maryland School of Medicine
  • 3:45 PM – 4:30 PM .
    Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:45 PM – 5:30 PM .
    Session X: Putting Your Knowledge to the Test: Challenging IBD cases
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
    Panelist: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Panelist: Florian Rieder, MD – Cleveland Clinic
    Panelist: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • Friday, May 19, 2023
  • 12:00 PM – 12:15 PM .
    Session I
  • 12:15 PM – 1:00 PM .
    Session I: 2023 Updates in IBD Management
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater: Powerful UC Results
  • 2:15 PM – 2:45 PM .
    Exhibit Hall Break
  • 2:45 PM – 3:30 PM .
    Session II: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 3:45 PM – 4:45 PM .
    Non-CME Innovation Theater: Exploring a Prescription Treatment for Patients with Moderately to Severely Active Ulcerative Colitis, Including Long-Term Data
  • 5:00 PM – 5:45 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Alan C. Moss, MD, FACG, AGAF, FRCPI – Boston University & Boston Medical Center
  • Saturday, May 20, 2023
  • 8:00 AM – 8:15 AM .
    Session IV
  • 8:15 AM – 9:00 AM .
    Session IV: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 9:15 AM – 10:30 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Alan C. Moss, MD, FACG, AGAF, FRCPI – Boston University & Boston Medical Center
  • 10:30 AM – 11:00 AM .
    Exhibit Hall Break
  • 11:00 AM – 12:00 PM .
    Non-CME Innovation Theater: Is It Time To Rethink Your Approach With Your Moderate UC Patients?
  • 12:15 PM – 1:00 PM .
    Session VI: Special Situations in IBD
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
  • 1:00 PM – 1:45 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 1:00 PM – 1:45 PM .
    Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
  • 2:00 PM – 3:00 PM .
    Non-CME Innovation Theater: Case by Case
  • 3:15 PM – 4:00 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:00 PM – 4:45 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases
  • Thursday, June 15, 2023
  • 12:00 PM – 1:00 PM .
    Welcome and Session I: 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater: Case by Case: an expert-led patient case study that reviews a hypothetical patient treated with SKYRIZI for moderate to severe CD
  • 2:30 PM – 3:15 PM .
    Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 3:30 PM – 4:30 PM .
    Non-CME Innovation Theater: Exploring a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis, Including Long-Term Data
  • 4:45 PM – 5:30 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Friday, June 16, 2023
  • 8:00 AM – 8:45 AM .
    Session IV: Special Situations in UC
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
  • 8:00 AM – 8:45 AM .
    Session VI: Special Situations in UC
  • 9:00 AM – 10:00 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 10:15 AM – 11:15 AM .
    Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 12:30 PM – 1:15 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
  • 2:45 PM – 3:30 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 3:45 PM – 4:30 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases
    Panelist: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
    Panelist: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • Friday, July 21, 2023
  • 12:00 PM – 12:15 PM .
    Session I
  • 12:15 PM – 1:00 PM .
    Session I - 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater
  • 2:45 PM – 3:30 PM .
    Session II - Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 3:45 PM – 4:45 PM .
    Non-CME Innovation Theater
  • 5:00 PM – 5:45 PM .
    Session III - Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Saturday, July 22, 2023
  • 8:00 AM – 8:15 AM .
    Session IV
  • 8:15 AM – 9:00 AM .
    Session IV - Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
    Speaker: Scott A. Strong, MD, FACS, FASCRS – Northwestern University Feinberg School of Medicine
  • 9:15 AM – 10:30 AM .
    Session V - Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 10:30 AM – 11:00 AM .
    Exhibit Hall Break
  • 11:00 AM – 12:00 PM .
    Non-CME Innovation Theater
  • 12:15 PM – 1:00 PM .
    Session VI - Special Situations in IBD
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
  • 1:00 PM – 1:45 PM .
    Session VII - Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • 2:00 PM – 3:00 PM .
    Non-CME Innovation Theater
  • 3:15 PM – 4:00 PM .
    Session VIII - Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:00 PM – 4:45 PM .
    Session IX - Putting your knowledge to the test: Challenging IBD cases
  • Thursday, August 17, 2023
  • 12:00 PM – 1:00 PM .
    Welcome and Session I: 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 2:30 PM – 3:15 PM .
    Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 3:30 PM – 4:15 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Friday, August 18, 2023
  • 8:00 AM – 8:45 AM .
    Session IV: Special Situations in UC
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
  • 9:00 AM – 10:00 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 12:30 PM – 1:15 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater
  • 2:45 PM – 3:30 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 3:45 PM – 4:30 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases
    Moderator: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • Thursday, September 14, 2023
  • 12:00 PM – 1:00 PM .
    Welcome and Session I: 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:15 PM – 2:15 PM .
    Non-CME Innovation Theater
  • 2:30 PM – 3:15 PM .
    Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 3:30 PM – 4:30 PM .
    Non-CME Innovation Theater
  • 4:45 PM – 5:30 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Friday, September 15, 2023
  • 8:00 AM – 8:45 AM .
    Session IV: Special Situations in UC
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
  • 9:00 AM – 10:00 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 10:15 AM – 11:15 AM .
    Non-CME Innovation Theater
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 12:30 PM – 1:15 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater
  • 2:45 PM – 3:30 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 3:45 PM – 4:30 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases